| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2000 | CN1052011C Vaccin peptide of blood fluke |
| 05/02/2000 | US6057450 Derivatives of pyroglutaminic acid preparation process and applications |
| 05/02/2000 | US6057437 Antisense nucleic acid compounds inhibiting vascular endothelial growth factor |
| 05/02/2000 | US6057436 Canine coronavirus S gene and uses therefor |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057434 Polynucleotide which encodes a protein of specific amino acid sequence; for anticarcinogenic/antitumor agents, diagnostic and screening assays |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057430 Treating denatured monomers of transforming growth factor-beta 3 with a folding buffer of a mild detergent and dimethyl sulfoxide, dimethyl sulfone and/or dimethylformamide increases yield of active dimers |
| 05/02/2000 | US6057428 Variants of vascular endothelial cell growth factor |
| 05/02/2000 | US6057427 Antibody or fragment which binds to specific amino acid sequence; for peptide/protein purification |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057425 Solid phase synthesis of peptides where prior to cleavage and deprotection, the protected resin peptide is reswelled with dichloromethane |
| 05/02/2000 | US6057423 Screening a recombinantly-produced or chemically-synthesized molecular library to identify compounds which suppress binding between human mucosal lymphocyte-1 antigen comprising an integrin alpha e chain and an epithelial cell in vitro |
| 05/02/2000 | US6057422 Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase |
| 05/02/2000 | US6057311 Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors |
| 05/02/2000 | US6057300 Introducing expression vector comprising gene encoding p21 and expression vector comprising second gene encoding immunotherapeutic agent, genetic therapeutic, cytokine or prodrug converting enzyme to treat restenosis |
| 05/02/2000 | US6057299 Isolated polynucleotide comprising prostate-specific enhancer which activates transcription of nucleotide sequence in human prostate cell, operably linked to polynucleotide sequence encoding heterologous polypeptide |
| 05/02/2000 | US6057297 Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof |
| 05/02/2000 | US6057295 Oligopeptides derived from C-reactive protein fragments |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6057291 Antimicrobial cationic peptides |
| 05/02/2000 | US6057290 Angiogenesis inhibitor |
| 05/02/2000 | US6057289 Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6057156 Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
| 05/02/2000 | US6057155 Nucleic acid encoding a chimeric adenovirus fiber protein constrained by a non-preexisting loop; for efficient, direct entry of the nucleic acid-containing vector into cells for targeted gene therapy |
| 05/02/2000 | US6057153 Oligonucleotide composed of modified nucleotides and having a ribonuclease p cleavage targeting sequence and a recognition sequence complementary to target rna; for viricides to treat hepatitis b infections |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057139 Preparing enzyme tablets for the treatment of lactose defects |
| 05/02/2000 | US6057138 Cysteinyl tRNA synthetase from Staphylococcus aureus |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6057127 Mammalian nucleotide sequences that code for antibody binding protein; for detection of antibody and immune response; for the diagnosis of allergies, parasitic infections and tumors |
| 05/02/2000 | US6057125 Clock gene and gene product |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057123 Stem cell inhibiting proteins |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057116 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057110 Human hyaluronidase |
| 05/02/2000 | US6057109 Compositions for the treatment of body weight disorders including obesity |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6057104 Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6057094 Methods and compositions for screening of human Borna disease virus |
| 05/02/2000 | US6056960 Pertussis toxin and its analogs exhibiting adp-ribosyltransferase activity; tumor-related antigen comprising tumor cells, irradiated tumor cells, or tumor-associated antigens |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056956 Non-depleting anti-CD4 monoclonal antibodies and tolerance induction |
| 05/02/2000 | US6056955 Topical treatment of streptococcal infections |
| 05/02/2000 | US6056954 Treatment of skin infections, wounds, and burns, eye infections |
| 05/02/2000 | US6056938 Cationic lipids and the use thereof |
| 05/02/2000 | US6056715 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2169362C Formulations for delivery of osteogenic proteins |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2063063C Antimicrobial peptide and an antimicrobial agent |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 05/02/2000 | CA2012480C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| 05/02/2000 | CA2012170C Novel method of ovulation induction in humans |
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023784A2 Method of detecting risk of type ii diabetes based on mutations found in carboxypeptidase e |
| 04/27/2000 | WO2000023625A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023610A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023591A2 Secreted protein zsig49 |
| 04/27/2000 | WO2000023590A2 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023587A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 04/27/2000 | WO2000023585A1 Cardiac troponin i polypeptide fragments and uses in diagnostics |
| 04/27/2000 | WO2000023584A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/27/2000 | WO2000023583A2 p53 BINDING AREAS |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023476A1 Neovascular-specific peptides |
| 04/27/2000 | WO2000023475A1 Intracellular c-terminal hdl-receptor domain |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023467A1 birA |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023462A1 Method for the production of purified invasin protein and use thereof |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023454A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/27/2000 | WO2000023116A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |